NM_020297.4(ABCC9):c.295T>A (p.Ser99Thr) AND Dilated cardiomyopathy 1O

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Oct 19, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001917845.4

Allele description [Variation Report for NM_020297.4(ABCC9):c.295T>A (p.Ser99Thr)]

NM_020297.4(ABCC9):c.295T>A (p.Ser99Thr)

Gene:

ABCC9:ATP binding cassette subfamily C member 9 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

12p12.1

Genomic location:

Preferred name:

NM_020297.4(ABCC9):c.295T>A (p.Ser99Thr)

HGVS:

NC_000012.12:g.21926053A>T
NG_012819.1:g.15642T>A
NM_001377273.1:c.295T>A
NM_001377274.1:c.-160T>A
NM_005691.4:c.295T>A
NM_020297.4:c.295T>AMANE SELECT
NP_001364202.1:p.Ser99Thr
NP_005682.2:p.Ser99Thr
NP_064693.2:p.Ser99Thr
LRG_377:g.15642T>A
NC_000012.11:g.22078987A>T
NM_005691.3:c.295T>A

Protein change:

S99T

Links:

dbSNP: rs1270249014

NCBI 1000 Genomes Browser:

rs1270249014

Molecular consequence:

NM_001377274.1:c.-160T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001377273.1:c.295T>A - missense variant - [Sequence Ontology: SO:0001583]
NM_005691.4:c.295T>A - missense variant - [Sequence Ontology: SO:0001583]
NM_020297.4:c.295T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Dilated cardiomyopathy 1O (CMD1O)
Synonyms:: CARDIOMYOPATHY, DILATED, WITH VENTRICULAR TACHYCARDIA
Identifiers:: MONDO: MONDO:0012062; MedGen: C1837839; Orphanet: 154; OMIM: 608569

Recent activity

Clear Turn Off Turn On

ze14c01.r1 Soares_fetal_heart_NbHH19W Homo sapiens cDNA clone IMAGE:358944 5', m...
ze14c01.r1 Soares_fetal_heart_NbHH19W Homo sapiens cDNA clone IMAGE:358944 5', mRNA sequence
gi|1424562|gnl|dbEST|602875|gb|W920

Nucleotide
Macrophage Activation Syndrome
Macrophage Activation Syndrome
A serious complication of childhood systemic inflammatory disorders that is thought to be caused by excessive activation and proliferation of T-LYMPHOCYTES and MACROPHAGES. It...<br/>Year introduced: 2009

MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002170678	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Oct 19, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002170678

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Oct 19, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002170678.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with ABCC9-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with threonine at codon 99 of the ABCC9 protein (p.Ser99Thr). The serine residue is highly conserved and there is a small physicochemical difference between serine and threonine.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine